Today's Health News

Five-Day Course of Remdesivir Beneficial in Severe COVID-19

No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation

1990 to 2017 Saw Increase in Prevalence, Incidence of Psoriasis

In addition, global burden of suffering related to psoriasis increased, with increases in YLDs, DALYs

Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers

Treatment strategies differ, but outcomes equivalent among adolescent, young adult Hodgkin patients

Infection Risk Up in Month After CAR T-Cell Immunotherapy

Infection rates increase in patients with ALL aged ≤26 years in first month, then decrease at days 29 to 90

Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease

MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality

Exposure to Urban Air Pollution May Up Risk of Multiple Sclerosis

Adjusted risk 29 percent higher among those residing in more urbanized areas

ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer

And, enzalutamide improves median overall survival in nonmetastatic, castration-resistant prostate cancer

Success More Than 50 Percent for Second Child With Fertility Treatment

Chances range from 51 to 88 percent depending on use of frozen versus fresh embryos

Burden of Severe COVID-19 High in California, Washington State

Length of stay was 9.3 days for survivors; probability high for ICU admission, mortality

Inequity Found in Access to Transplant With Universal Health Care

Patient factors including socioeconomic status account for much variation in kidney transplant access